A concise review on advances in development of small molecule anti-inflammatory therapeutics emphasising AMPK: An emerging target

Chethan Gejjalagere Honnappa, Unnikrishnan Mazhuvancherry Kesavan

Research output: Contribution to journalReview article

6 Citations (Scopus)


Inflammatory diseases are complex, multi-factorial outcomes of evolutionarily conserved tissue repair processes. For decades, non-steroidal anti-inflammatory drugs and cyclooxygenase inhibitors, the primary drugs of choice for the management of inflammatory diseases, addressed individual targets in the arachidonic acid pathway. Unsatisfactory safety and efficacy profiles of the above have necessitated the development of multi-target agents to treat complex inflammatory diseases. Current anti-inflammatory therapies still fall short of clinical needs and the clinical trial results of multi-target therapeutics are anticipated. Additionally, new drug targets are emerging with improved understanding of molecular mechanisms controlling the pathophysiology of inflammation. This review presents an outline of small molecules and drug targets in anti-inflammatory therapeutics with a summary of a newly identified target AMP-activated protein kinase, which constitutes a novel therapeutic pathway in inflammatory pathology.

Original languageEnglish
Pages (from-to)562-571
Number of pages10
JournalInternational Journal of Immunopathology and Pharmacology
Issue number4
Publication statusPublished - 01-12-2016
Externally publishedYes


All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this